FDA Inspection 1168336 — Gulf Coast Regional Blood Center At Baytown
The FDA completed an inspection of Gulf Coast Regional Blood Center At Baytown on Apr 28, 2022 in Baytown, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 28, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Baytown, TX (United States)